Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results 2022-05-09 18:30
AskGene Limited Announces Completion of USD 20 Million Series A Financing Led by Qiming Venture Partners and TF Capital 2022-05-09 11:37
JW Therapeutics to Present Latest Data of Carteyva® at 2022 ASCO Annual Meeting 2022-05-09 09:00
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers 2022-05-09 08:04
Aravax appoints Dr Brett Haumann to Board of Directors 2022-05-06 21:00
VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update 2022-05-06 20:00
Harbour BioMed Appoints Dr. Alexander A. Zukiwski to its Scientific Advisory Board 2022-05-06 08:00
AHRA and United Imaging launch a new program to develop exceptional leaders. 2022-05-05 22:15
Daewoong Pharmaceutical announced first-quarter 2022 results 2022-05-05 21:00
Bon Natural Life Limited Advances Towards Near Term Production and Completes Building Construction of Yumen Plant 2022-05-05 21:00
I-Mab Provides Updates on Status under Holding Foreign Companies Accountable Act 2022-05-05 20:00
Zepp Health Corporation Provides Update on its Status under the Holding Foreign Companies Accountable Act 2022-05-05 20:00
111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act 2022-05-05 17:18
Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma 2022-05-04 20:36
United Imaging Flips the Script on its Events Program for 2022, Reveals Expanded Sales Force and U.S. Growth 2022-05-03 23:22
China Natural Resources Receives Nasdaq Notification Regarding Minimum Bid Requirements 2022-05-03 04:05
WATERDROP ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR 2022-05-02 20:00
Inmagene Receives FDA's IND Clearance for OX40 Antagonist 2022-05-01 06:00
Concord Medical Files 2021 Annual Report on Form 20-F 2022-04-30 07:15
IONOVA Announces Clinical Trial Collaboration with MSD to Evaluate INV-1120 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors 2022-04-29 20:00
1 160 161 162 163 164 801